Japanese Stock News

TSE:4568
TSE:4568Pharmaceuticals

ENHERTU’s Early Breast Cancer Approval Might Change The Case For Investing In Daiichi Sankyo Company (TSE:4568)

Daiichi Sankyo and AstraZeneca recently received US FDA approval for ENHERTU in both neoadjuvant and adjuvant treatment of HER2-positive early breast cancer, unlocking US$155 million in milestone payments to Daiichi Sankyo and adding to an already broad label that spans multiple tumor types and disease stages. This move brings ENHERTU into earlier, potentially curative treatment settings while reinforcing Daiichi Sankyo’s DXd-based antibody-drug conjugate platform as a central pillar of its...
TSE:5970
TSE:5970Auto Components

Asian Dividend Stocks To Consider In May 2026

As of mid-May 2026, Asian markets are navigating a complex landscape shaped by rising energy costs and inflationary pressures, which have influenced investor sentiment across the region. Amid these challenges, dividend stocks in Asia offer a potential avenue for investors seeking income stability and resilience in volatile market conditions. Identifying strong dividend stocks often involves looking for companies with robust cash flows and a history of consistent payouts, qualities that can be...
TSE:4716
TSE:4716Software

Exploring High Growth Tech Stocks In Asia May 2026

As inflation pressures rise amid higher energy costs, major Asian markets have shown mixed performance with investor sentiment being influenced by geopolitical uncertainties and economic indicators. In this environment, identifying high growth tech stocks in Asia requires a focus on companies that demonstrate resilience and adaptability to shifting market dynamics while capitalizing on emerging technological trends.